Doctors seek best blood thinner combo for dangerous clotting disorder
NCT ID NCT05646394
Summary
This study is creating a registry to compare the safety and effectiveness of different blood-thinning medication combinations for people with antiphospholipid syndrome (APS) who have recently had an artery clot. It will follow 150 adult patients for two years, tracking whether they have another clot or a serious bleeding event. The goal is to gather real-world evidence on which treatment approach works best to prevent future clots while minimizing bleeding risks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinica Universitaria Reina Fabiola
RECRUITINGCórdoba, Argentina
Contact Phone: •••-•••-••••
-
Instituto de Investigaciones en Salud Pública, Universidad de Buenos Aires
RECRUITINGBuenos Aires, Buenos Aires F.D., C1113 AAJ, Argentina
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
McMaster University
RECRUITINGHamilton, Ontario, L9H 7M1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.